Pembrolizumab works by blocking a mechanism that cancer cells use to evade detection by the immune system, according to Drugs.com. The U.S. Food and Drug Administration (FDA) first approved it in 2014 ...

Routine screening prevents around 1,300 deaths from breast cancer each year in the UK, but AI-supported mammography screenings could save more lives ...

Ancestry-specific biomarkers, such as POLB, could reshape diagnostic and prognostic approaches in head and neck cancer. New ...

A groundbreaking study from Brown University Health researchers has identified a crucial factor that may help improve ...

Some committee members asked for courts and places of worship to also be covered in the bill, while some constituents went ...

AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...

Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a ...

Residents are taking up the call for ‘no work, no school and no shopping’ on Friday, as part of a nationwide day of action.

Researchers in Sweden and the Netherlands have suggested an emerging screening tool may be better at detecting deadly cancers ...

A new wave of supremely agile players has arrived in the professional circuit, challenging the traditional approach to the ...

Terminally ill cancer patient Sonya Corris, 53, from Essex, was left with no source of income after waiting weeks for her terminal illness claims ...

A 38-year-old Palm Beach County man pleaded guilty for his role in a scheme to defraud Medicare by submitting over $52 million in false and fraudulent claims for genetic testing.